Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
974 INR | +0.45% | -5.81% | +20.05% |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
05-08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
Chart: Technical Analysis
Technical analysis trends
Short Term | Mid-Term | Long Term | |
---|---|---|---|
Trend | Neutral | Bullish | Bullish |
Resistance | 1,034.10 | 1,064.45 | 1,034.10 |
Spread/Res. | -5.81% | -8.50% | -5.81% |
Spread/Supp. | +2.31% | +10.68% | +22.39% |
Support | 952.05 | 880.00 | 795.80 |
Technical Rankings Surperformance
Short Term Timing | |
---|---|
Middle Term Timing | |
Long Term Timing | |
RSI | |
Bollinger Spread | |
Unusual Volumes |
- Stock Market
- Equities
- NATCOPHARM Stock
- Charts NATCO Pharma Limited